NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 124 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $368,156 | -59.7% | 344,071 | -2.5% | 0.00% | – |
| Q2 2023 | $914,399 | -36.7% | 353,050 | -0.3% | 0.00% | – |
| Q1 2023 | $1,444,410 | -16.5% | 354,022 | +2.7% | 0.00% | – |
| Q4 2022 | $1,730,290 | -61.0% | 344,679 | +1.7% | 0.00% | -100.0% |
| Q3 2022 | $4,434,000 | +1.3% | 339,071 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $4,375,000 | -2.1% | 341,251 | +16.4% | 0.00% | 0.0% |
| Q1 2022 | $4,470,000 | -17.1% | 293,106 | -3.7% | 0.00% | 0.0% |
| Q4 2021 | $5,394,000 | -14.3% | 304,514 | +1.7% | 0.00% | 0.0% |
| Q3 2021 | $6,295,000 | +7.3% | 299,460 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $5,866,000 | -26.3% | 297,440 | +8.6% | 0.00% | 0.0% |
| Q1 2021 | $7,960,000 | -2.5% | 273,840 | +1.6% | 0.00% | -50.0% |
| Q4 2020 | $8,164,000 | +86.1% | 269,472 | -2.3% | 0.00% | +100.0% |
| Q3 2020 | $4,386,000 | -15.1% | 275,696 | +5.4% | 0.00% | 0.0% |
| Q2 2020 | $5,165,000 | +58.4% | 261,639 | -1.0% | 0.00% | 0.0% |
| Q1 2020 | $3,260,000 | -32.8% | 264,402 | +0.8% | 0.00% | 0.0% |
| Q4 2019 | $4,849,000 | +246.1% | 262,239 | +159.1% | 0.00% | – |
| Q3 2019 | $1,401,000 | +107.6% | 101,211 | +119.7% | 0.00% | – |
| Q2 2019 | $675,000 | – | 46,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |